Irene Recio-Gonzalez
Bizkaia Technology Park
Derio, PV, Spain
Derio, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Metabolic dysfunction-associated steatotic liver disease alters brain function and behavior: Insights from liver-targeted siRNA therapy.
Journal: Science advances
Published: October 22, 2025
Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathway.
Journal: Molecular metabolism
Published: October 19, 2025
Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: October 16, 2025
Disruption of Reelin signaling in a dual-hit mouse model of schizophrenia: impact of postnatal Δ9-tetrahydrocannabinol exposure in a maternal immune activation model.
Journal: Translational psychiatry
Published: August 26, 2025
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism.
Journal: British journal of cancer
Published: June 26, 2025
NEDD8-specific protease 1 deficiency as a novel driver of hepatoblastoma development through dysregulation of the CAND1-NEDD8 pathway.
Journal: Hepatology (Baltimore, Md.)
Published: April 03, 2025
Modulatory effects of CNNM4 on protein- l -isoaspartyl- O -methyltransferase repair function during alcohol-induced hepatic damage.
Journal: Hepatology (Baltimore, Md.)
Published: March 23, 2024
The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis.
Journal: Metabolism: clinical and experimental
Published: February 22, 2024
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway.
Journal: Cell reports. Medicine
Published: September 27, 2023
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.
Journal: JHEP reports : innovation in hepatology
Published: February 18, 2023
Last Updated: 09/26/2026